There were more than 90% of systemic sclerosis (SSc) patients developing gastrointestinal tract involvement with affecting esophagus mostly. However, a typical gastrointestinal manifestation may be not the only result of SSc. We described a 70-year-old female with SSc presented poor appetite, intermittent heartburn sensation, nausea, frequent sensation of abdominal fullness, and intermittent dull pain for 2 months. The esophagogastroduodenoscopy showed gastrointestinal as gastroesophageal reflux disease. The biopsy revealed amorphous material deposited in the vascular walls and apple-green birefringence in a polarization examination with Congo red staining which proved amyloidosis. The SSc patient with gastrointestinal involvement suggests ...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
International audienceIn systemic sclerosis (SSc), esophageal and anorectal involvements are frequen...
Absence of antitopoisomerase I antibodies and presence of antibodies to RNA-Polymerase-III antibod...
Systemic sclerosis is an autoimmune chronic disease characterised by microvascular, muscular and imm...
Aim: Esophagus is the most frequently involved gastrointestinal segment in systemic sclerosis (SS). ...
The gastrointestinal (GI) tract can be involved in up to 90% of patients with systemic sclerosis (SS...
The gastrointestinal tract (GIT) is the most common extracutaneous organ system damaged in systemic ...
Amyloidosis is a rare disease caused by extracellular deposits of insoluble fibrillar proteins in va...
We report this case of a 42-year-old woman who presented with a debilitating illness manifested by i...
Systemic amyloidosis is a group of complex disorders characterized by the extracellular deposition o...
Systemic sclerosis (SSc) is a rare disorder associating vasculopathy, tissue fibrosis and autoimmuni...
Systemic sclerosis (SSc) is a multisystem autoimunne disorder that involves the gastrointestinal t...
Amyloidosis is characterized by the accumulation of an insoluble amyloid protein in the extracellula...
Progressive systemic sclerosis (PSS) is a connective tissue disease that may affect many organs, inc...
Amyloidosis involves all parts of the gastrointestinal tract including the esophagus. The esophageal...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
International audienceIn systemic sclerosis (SSc), esophageal and anorectal involvements are frequen...
Absence of antitopoisomerase I antibodies and presence of antibodies to RNA-Polymerase-III antibod...
Systemic sclerosis is an autoimmune chronic disease characterised by microvascular, muscular and imm...
Aim: Esophagus is the most frequently involved gastrointestinal segment in systemic sclerosis (SS). ...
The gastrointestinal (GI) tract can be involved in up to 90% of patients with systemic sclerosis (SS...
The gastrointestinal tract (GIT) is the most common extracutaneous organ system damaged in systemic ...
Amyloidosis is a rare disease caused by extracellular deposits of insoluble fibrillar proteins in va...
We report this case of a 42-year-old woman who presented with a debilitating illness manifested by i...
Systemic amyloidosis is a group of complex disorders characterized by the extracellular deposition o...
Systemic sclerosis (SSc) is a rare disorder associating vasculopathy, tissue fibrosis and autoimmuni...
Systemic sclerosis (SSc) is a multisystem autoimunne disorder that involves the gastrointestinal t...
Amyloidosis is characterized by the accumulation of an insoluble amyloid protein in the extracellula...
Progressive systemic sclerosis (PSS) is a connective tissue disease that may affect many organs, inc...
Amyloidosis involves all parts of the gastrointestinal tract including the esophagus. The esophageal...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
International audienceIn systemic sclerosis (SSc), esophageal and anorectal involvements are frequen...
Absence of antitopoisomerase I antibodies and presence of antibodies to RNA-Polymerase-III antibod...